NDC 0069-0251 – Xalkori
Crizotinib 20 mg/1 · Capsule, Coated Pellets · Oral
Product NDC0069-0251
Product details
- Brand name
- Xalkori
- Generic name
- Crizotinib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Capsule, Coated Pellets
- Route
- Oral
- Marketing category
- NDA · NDA217581
- Marketed since
- November 20, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Crizotinib 20 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0251-60 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (0069-0251-60) | Nov 20, 2023 |
Other Xalkori products
- 0069-0507 Crizotinib 50 mg/1 · Capsule, Coated Pellets · Pfizer Laboratories Div Pfizer Inc
- 0069-1500 Crizotinib 150 mg/1 · Capsule, Coated Pellets · Pfizer Laboratories Div Pfizer Inc
- 0069-8140 Crizotinib 250 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-8141 Crizotinib 200 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc